Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 6 Sep 24 EFFECT Notice of effectiveness
- 5 Sep 24 425 Business combination disclosure
- 5 Sep 24 424B3 Prospectus supplement
- 26 Aug 24 F-4/A Registration of securities (foreign) (amended)
- 9 Aug 24 F-4/A Registration of securities (foreign) (amended)
- 19 Jul 24 F-4/A Registration of securities (foreign) (amended)
- 20 Jun 24 F-4/A Registration of securities (foreign) (amended)
- 18 Mar 24 425 Business combination disclosure
- 15 Mar 24 F-4/A Registration of securities (foreign) (amended)
- 26 Jan 24 425 Business combination disclosure
- 19 Jan 24 F-4/A Registration of securities (foreign) (amended)
- 12 Dec 23 425 Business combination disclosure
- 28 Nov 23 F-4/A Registration of securities (foreign) (amended)
- 22 Nov 23 425 Business combination disclosure
-
21 Aug 23 F-4 Registration of securities (foreign)
BDMD similar filings
Filing view
External links
Exhibit 99.3
CONSENT OF STEVEN T. HALVERSON
In connection with the filing by Baird Medical Investment Holdings Limited (the “Company”) of its Registration Statement (the “Registration Statement”) on Form F-4 with the Securities and Exchange Commission under the Securities Act of 1933, as amended (the “Securities Act”), I hereby consent, pursuant to Rule 438 of the Securities Act, to being named as a nominee to the board of directors of the Company in the Registration Statement and any and all amendments and supplements thereto. I also consent to the filing of this consent as an exhibit to such Registration Statement and any amendments and supplements thereto.
Dated: August 21, 2023 | |
/s/ Steven T. Halverson | |
STEVEN T. HALVERSON |